Skip to main content
OpenTrials

Clinical trial condition

Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive

Explore clinical trials studying Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive trial results

Not Yet Recruiting

A Phase 2 Study of ABSK043 Combined With Osimertinib

NCT07710612

Conditions
Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
Locations
  • The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • The First Hospital of China Medical University Shenyang, Liaoning, China
View Trial Details